Global and Canadian Perspectives from 16 Years of GeNeSIS*
At the end of the session, participants will be better able to:
• Describe the role of observational studies in monitoring the use of growth hormone
• Identify the key results of the GeNeSIS study from an international and Canadian perspective
• Discuss the clinical application of the GeNeSIS results
• The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)
Cheri Deal, Ph.D., M.D.
Chief of Endocrinology, CHU Ste-Justine
Professor of Pediatrics,
Université de Montréal
Susan E. Kirsch, M.D.
Pediatric Endocrinologist, Markham Stouffville Hospital, Ontario
Consultant Clinical Research Physician,
Eli Lilly Canada Inc.
Chris Child, Ph.D.
Research Advisor – Endocrinology
Eli Lilly and Company, United Kingdom
7:00 pm Welcome and an Introduction to GH History in Canada Cheri Deal Ph.D., M.D,
7:20 pm Global Data Chris Child, Ph.D
8:00 pm Canadian Data Susan E. Kirsch, M.D.
8:40 pm Question & Answer Cheri Deal, Ph.D., M.D.
8:55 pm Closing Remarks Cheri Deal, Ph.D., M.D.
Thursday, February 9th from 7:00 pm to 9:00 pm
The Hamilton Convention Centre
1 Summers Lane
Hamilton ON L8P 4Y2
Dinner will be provided
To register for this satellite symposium, please send an email to: email@example.com